GlassScriptPhysician profile
Rajesh G Laungani
NPI 1447452396
$33,118.86
in general payments reported to CMS, 2019-2025
57 companies · $1,954 in 2025
The $1,954 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,910 · 2020: $9,744 · 2021: $6,267 · 2022: $2,309 · 2023: $2,616 · 2024: $3,319 · 2025: $1,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,246 · Travel and Lodging: $614 · Gift: $24.99 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,245.59 |
| Travel and Lodging | $613.68 |
| Gift | $24.99 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $9,457.18 | 2020-2025 | Tenoglide |
| Intuitive Surgical, INC. | $7,730.94 | 2019-2025 | Da Vinci Surgical System |
| Biocompatibles, INC. | $5,402.20 | 2019 | |
| Medtronic, INC. | $1,047.55 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $842.96 | 2019-2025 | Lithovue, General - Therapies, Ams 700 |
| Teleflex LLC | $789.00 | 2022-2024 | Urolift |
| Abbvie INC. | $641.20 | 2019-2025 | |
| Astellas Pharma US INC | $638.25 | 2019-2025 | Xtandi, Myrbetriq |
| Coloplast Corp | $557.99 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $522.16 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $457.12 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $445.43 | 2019-2024 | |
| Pfizer INC. | $443.51 | 2019-2025 | |
| Procept Biorobotics Corporation | $333.83 | 2019-2024 | Aquabeam System, Aquabeam Robotic System |
| Myovant Sciences INC. | $277.20 | 2021-2022 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Laungani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.